TECH - Citi downgrades Bio-Techne to neutral cites valuation
2024-05-22 14:32:33 ET
More on Bio-Techne
- Bio-Techne Corporation (TECH) Q3 2024 Earnings Call Transcript
- Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
- Bio-Techne Non-GAAP EPS of $0.48 beats by $0.02, revenue of $303.4M beats by $10.7M
- Bio-Techne Q3 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Bio-Techne